An investigational drug (Favipiravir) study for patients who have been hospitalized with the coronavirus COVID-19.
4 Studies found
Seeking men and women who are in the hospital and diagnosed with COVID-19 for a study of an investigational drug to see if it acts as an anti-viral and anti-inflammatory treatment for COVID-19 infection.
Seeking people aged 12 and older who have been diagnosed with COVID-19 for an experimental treatment made from blood donated by people who have recovered from COVID-19.
Seeking hospitalized men and women who are receiving mechanical ventilation due to COVID-19 for a study to evaluate the efficacy and safety of an investigational drug.